Eli Lilly Corp. buy BMO Capital Markets
Start price
03.07.24
/
50%
€842.00
Target price
03.07.25
€928.23
Performance (%)
-3.93%
Price
04.10.24
€807.70
Summary
This prediction is currently active. With a performance of -3.93%, the BUY prediction by BMO_Capital_Markets is trending in the wrong direction. Dividends of €1.18 are taken into consideration when calculating the performance. This prediction currently runs until 03.07.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | -1.365% | -1.365% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by BMO_Capital_Markets for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $1,001.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€936.94
01.05.25
01.05.25
11.47%
04.10.24
04.10.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€666.00
07.02.24
07.02.24
€802.46
07.02.25
07.02.25
21.82%
04.10.24
04.10.24